Deals
BioMed Said Exploring Sale, With Interest From Blackstone
- REIT is working with Morgan Stanley to consider options
- Shares climb as much as 13% for biggest gain since 2009
This article is for subscribers only.
BioMed Realty Trust Inc., a landlord with properties catering to biotechnology companies, is exploring a sale and has drawn interest from firms including Blackstone Group LP, according to people familiar with the talks.
The San Diego-based real estate investment trust, with a market value of $3.9 billion as of Tuesday, is working with Morgan Stanley on a potential deal, said the people, who asked not to be identified because the negotiations are private. Talks are ongoing and there’s no guarantee a deal will get done, one of the people said.